Advertisement
American Journal of Kidney Diseases

Effect of Daily Hemodialysis on Depressive Symptoms and Postdialysis Recovery Time: Interim Report From the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study

Published:August 05, 2010DOI:https://doi.org/10.1053/j.ajkd.2010.04.019

      Background

      Clinical depression and postdialysis fatigue are important concerns for patients with kidney failure and can have a negative impact on quality of life and survival.

      Study Design

      The FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study is an ongoing prospective cohort study investigating the clinical and economic benefits of daily (6 times per week) hemodialysis (HD). In this interim report, as part of an a priori planned analysis, we examine the long-term impact of daily HD on depressive symptoms, measured using the Beck Depression Inventory (BDI) survey, and postdialysis recovery time, measured using a previously validated questionnaire.

      Setting & Participants

      Adult patients initiating daily HD with a planned 12-month follow-up.

      Outcomes & Measurements

      The BDI survey and postdialysis recovery time question were administered at baseline, and changes were assessed at months 4 and 12.

      Results

      239 participants were enrolled (intention-to-treat cohort) and 128 completed the study (per-protocol cohort). Mean age was 52 years, 64% were men, 55% had an arteriovenous fistula, and 90% transitioned from in-center HD therapy. In the per-protocol cohort, there was a significant decrease in mean BDI score over 12 months (11.2 [95% CI, 9.6-12.9] vs 7.8 [95% CI, 6.5-9.1]; P < 0.001). For robustness, the intention-to-treat analysis was performed, yielding similar results. The percentage of patients with depressive symptoms (BDI score >10) significantly decreased during 12 months (41% vs 27%; P = 0.03). Similarly, in the per-protocol cohort, there was a significant decrease in postdialysis recovery time over 12 months (476 [95% CI, 359-594] vs 63 minutes [95% CI, 32-95]; P < 0.001). The intention-to-treat analysis yielded similar results. The percentage of patients experiencing prolonged postdialysis recovery time (≥60 minutes) also significantly decreased (81% vs 35%; P = 0.001).

      Limitations

      Observational study with lack of control arm.

      Conclusions

      Daily HD is associated with long-term improvement in depressive symptoms and postdialysis recovery time.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Hedayati S.
        • Bosworth H.
        • Kuchibhatla M.
        • Kimmel P.
        • Szczech L.
        The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients.
        Kidney Int. 2006; 69: 1662-1668
        • Finkelstein F.
        • Wuerth D.
        • Troidle L.
        • Finkelstein S.
        Depression and end-stage renal disease: a therapeutic challenge.
        Kidney Int. 2008; 74: 843-845
        • Parfrey P.
        • Vavasour H.
        • Bullock M.
        • et al.
        Symptoms in end-stage renal disease: dialysis vs. transplantation.
        Transplant Proc. 1987; 19: 3407-3409
        • Abuelo J.G.
        • Shemin D.
        • Chazan J.A.
        Acute symptoms produced by hemodialysis: a review of their causes and associations.
        Semin Dial. 1993; 6: 59-69
        • Lindsay R.M.
        • Heidenheim P.A.
        • Nesrallah G.
        • Garg A.X.
        • Suri R.
        Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change.
        Clin J Am Soc Nephrol. 2006; 1: 952-959
        • Lopes A.A.
        • Albert J.M.
        • Young E.W.
        • et al.
        Screening for depression in hemodialysis patients: associations with diagnosis, treatment, and outcomes in the DOPPS.
        Kidney Int. 2004; 66: 2047-2053
        • Beck A.
        Depression: Causes and Treatment.
        University of Pennsylvania Press, Philadelphia, PA1972
        • Ambrosini P.
        • Metz C.
        • Bianchi M.
        • Rabinovich H.
        • Undie A.
        Concurrent validity and psychometric properties of the Beck Depression Inventory in outpatient adolescents.
        J Am Acad Child Adolesc Psychiatry. 1991; 30: 51-57
        • Brown G.
        • Hammen C.
        • Craske M.
        • Wickens T.
        Dimensions of dysfunctional attitudes as vulnerabilities to depressive symptoms.
        J Abnorm Psychol. 1995; 104: 431-435
        • Hedayati S.S.
        • Minhajuddin A.T.
        • Toto R.D.
        • Morris D.W.
        • Rush A.J.
        Validation of depression screening scales in patients with CKD.
        Am J Kidney Dis. 2009; 54: 433-439
        • Watnick S.
        • Wang P.
        • Demadura T.
        • Ganzini L.
        Validation of two depression screening tools in dialysis patients.
        Am J Kidney Dis. 2005; 46: 919-924
        • Lopes A.A.
        • Bragg J.
        • Young E.
        • et al.
        Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe.
        Kidney Int. 2002; 62: 199-207
        • Ahmad S.
        • Robertson H.T.
        • Golper T.A.
        • et al.
        Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects.
        Kidney Int. 1990; 38: 912-918
        • Chan C.
        • Floras J.
        • Miller J.
        • Richardson R.
        • Pierratos A.
        Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis.
        Kidney Int. 2002; 61: 2235-2239
        • Nesrallah G.
        • Suri R.
        • Moist L.
        • Kortas C.
        • Lindsay R.
        Volume control and blood pressure management in patients undergoing quotidian hemodialysis.
        Am J Kidney Dis. 2003; 42: S13-S17
        • Reynolds J.T.
        • Homel P.
        • Cantey L.
        • et al.
        A one-year trial of in-center daily hemodialysis with an emphasis on quality of life.
        Blood Purif. 2004; 22: 320-328
        • Walsh M.
        • Culleton B.
        • Tonelli M.
        • Manns B.
        A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life.
        Kidney Int. 2005; 67: 1500-1508
        • Culleton B.F.
        • Walsh M.
        • Klarenbach S.W.
        • et al.
        Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial.
        JAMA. 2007; 298: 1291-1299
        • Jaber B.L.
        • Finkelstein F.O.
        • Glickman J.D.
        • et al.
        Scope and design of the Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements (FREEDOM) Study.
        Am J Kidney Dis. 2009; 53: 310-320
        • Clase C.M.
        • St Pierre M.W.
        • Churchill D.N.
        Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease.
        Nephrol Dial Transplant. 2001; 16: 1925-1929
        • Daugirdas J.T.
        Second generation logarithmic estimates of single-pool variable volume: an analysis of error.
        J Am Soc Nephrol. 1993; 4: 1205-1213
        • National Kidney Foundation
        KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy and vascular access.
        Am J Kidney Dis. 2006; 48: S1-S322
        • Kimmel P.L.
        • Peterson R.A.
        • Weihs K.L.
        • et al.
        Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients.
        Kidney Int. 2000; 57: 2093-2098
        • Wuerth D.
        • Finkelstein S.H.
        • Ciarcia J.
        • Peterson R.
        • Kliger A.S.
        • Finkelstein F.O.
        Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis.
        Am J Kidney Dis. 2001; 37: 1011-1017
        • National Kidney Foundation
        KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 update of hemoglobin target.
        Am J Kidney Dis. 2007; 50: 471-530
        • US Renal Data System
        USRDS 2008 Annual Data Report.
        National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD2008
        • Mapes D.L.
        • Lopes A.A.
        • Satayathum S.
        • et al.
        Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
        Kidney Int. 2003; 64: 339-349
        • Wuerth D.
        • Finkelstein S.H.
        • Finkelstein F.O.
        The identification and treatment of depression in patients maintained on dialysis.
        Semin Dial. 2005; 18: 142-146
        • Cohen S.D.
        • Norris L.
        • Acquaviva K.
        • Peterson R.A.
        • Kimmel P.L.
        Screening, diagnosis, and treatment of depression in patients with end-stage renal disease.
        Clin J Am Soc Nephrol. 2007; 2: 1332-1342
        • Hedayati S.S.
        • Bosworth H.B.
        • Briley L.P.
        • et al.
        Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression.
        Kidney Int. 2008; 74: 930-936
        • Cukor D.
        • Peterson R.
        • Cohen S.
        • Kimmel P.
        Depression in end-stage renal disease hemodialysis patients.
        Nat Clin Pract. 2006; 2: 678-687
        • Hedayati S.
        • Finkelstein F.
        Epidemiology, diagnosis, and management of depression in patients with chronic kidney disease.
        Am J Kidney Dis. 2009; 54: 741-752